Janux Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Janux Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q2 2024.
  • Janux Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -8.2 %, a 56.6% increase year-over-year.
  • Janux Therapeutics, Inc. annual Return On Assets for 2023 was -16 %, a 5.51% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -8.2 +10.7 +56.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -12.4 +5.79 +31.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -16 +0.93 +5.51% Oct 1, 2023 Dec 31, 2023
Q3 2023 -17.3 -1.32 -8.25% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.9 -4.6 -32.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.2 -6.76 -59.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -16.9 Oct 1, 2022 Dec 31, 2022
Q3 2022 -16 Jul 1, 2022 Sep 30, 2022
Q2 2022 -14.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -11.4 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.